Understanding Drivers of Ocular Fibrosis: Current and Future Therapeutic Perspectives
Ocular fibrosis leads to severe visual impairment and blindness worldwide, being a major area of unmet need in ophthalmology and medicine. To date, the only available treatments are antimetabolite drugs that have significant potentially blinding side effects, such as tissue damage and infection. The...
Guardado en:
Autores principales: | Fabiana Mallone, Roberta Costi, Marco Marenco, Rocco Plateroti, Antonio Minni, Giuseppe Attanasio, Marco Artico, Alessandro Lambiase |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb71e9d22f7f40b3b57e8b81fe01434e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ocular lubricant use in medically and surgically treated glaucoma: a retrospective longitudinal analysis
por: Iyer JV, et al.
Publicado: (2017) -
Trends in the characteristics of vitrectomy in Eastern China
por: Fang Y, et al.
Publicado: (2018) -
Current Situation and Prospect of Teleophthalmology
por: ZHANG Xiao, et al.
Publicado: (2021) -
Macular pigment optical density: repeatability, intereye correlation, and effect of ocular dominance
por: Davey PG, et al.
Publicado: (2016) -
Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution
por: Lee D, et al.
Publicado: (2017)